| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | Chief Science Officer Virology | Common Stock | 115,971 | $296,885 | $2.56 | 12 Dec 2025 | Direct |
| Traws Pharma, Inc. | Chief Science Officer Virology | Stock Option (right to purchase) | 73,886 | 12 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | 12 Dec 2025 | 2 | $0 | 4 | Chief Science Officer Virology | 16 Dec 2025, 18:16 |
| TRAW | Traws Pharma, Inc. | 12 Oct 2025 | 1 | $0 | 4 | Chief Science Officer Virology | 15 Oct 2025, 20:08 |
| TRAW | Onconova Therapeutics, Inc. | 01 Apr 2024 | 3 | $0 | 4 | Chief Science Officer Virology | 03 Apr 2024, 20:04 |
| TRAW | Onconova Therapeutics, Inc. | 01 Apr 2024 | 0 | $0 | 3 | Chief Science Officer Virology | 03 Apr 2024, 19:54 |